Intracerebral Hemorrhage (ICH)

2

Review clinical trials related to Intracerebral Hemorrhage (ICH). Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Improving the Prognosis for Cerebral Hemorrhage A Study of Clinical, Biological, and Imaging Markers

This study will establish a prospective, multicenter national cohort of patients with spontaneous intracerebral hemorrhage (ICH). A standardized multimodal database integrating clinical, biological, and imaging data will be collected. The study aims to better characterize ICH patient phenotypes, identify diagnostic and prognostic biomarkers, and describe adherence to evidence-based acute management strategies, including the proportion of patients managed according to the care bundle validated in the INTERACT 3 study. The cohort is also intended to provide a structured platform for translational research and the preparation of future stratified interventional clinical trials in spontaneous ICH.

Participants needed: 10,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, ToursUpdated: May 6, 2026Locations: 4Duration: 2 Years
Eligibility criteria

Age ≥ 18 years; [+2]

First brain imaging performed outside a center participating in the study (e.g.,... [+6]

Status: Not yet recruiting

Research on the Clinical Value of Cranial CT and CTA for Cerebral Hemorrhage Patients

The objective of this observational study is to investigate the predictive value of various imaging signs in patients with intracerebral hemorrhage, thereby providing a reference for clinical diagnosis and treatment. The primary aim is to evaluate the association between specific imaging signs and both hematoma expansion and poor outcomes in these patients.

Participants needed: 300
Trial details
Biological sex: AllType: ObservationalSponsor: The Affiliated Hospital Of Guizhou Medical UniversityUpdated: Aug 3, 2025Duration: 6 Months
Eligibility criteria

Not listed